|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0700 - 0.0700|
|52 Week Range||0.0400 - 0.2670|
|Beta (5Y Monthly)||4.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul. 01, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
22nd Century Takes Ownership of Needle Rock Farms, Provides North American Cultivation Base of OperationsBUFFALO, N.Y., July 01, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced it has signed a definitive agreement to restructure its strategic investment in Panacea Life Sciences, Inc., in line with the ongoing development of
Leslie Buttorff, Founder of Panacea, To Lead Combined Companies as Chief Executive OfficerDELRAY BEACH, FL / ACCESSWIRE / July 1, 2021 / Exactus, Inc. (OTCQB:EXDI) (the "Company") a leading supplier of hemp-derived ingredients (CBD/CBG), today announced the acquisition of Panacea Life Sciences, Inc.
Third Quarter 2020 Highlights * Total Net Revenue of $678,050 * Achieved Gross Profit of $114,529 * Continuation of Sales & Marketing Buildout * Alibaba Storefront LaunchDELRAY BEACH, FL / ACCESSWIRE / November 19, 2020 / Exactus, Inc.